VANGUARD GROUP INC

Position in ANEB — Anebulo Pharmaceuticals, Inc.

CIK 102909 Valley Forge, PA

Position in ANEB

as of Dec 31, 2025 · filed Jan 29, 2026 Compact

Position Value

$440,178

-$326,171 QoQ

Shares Held

435,821

+42.2% QoQ

Ownership

1.07%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 19 holders

Holding Since

Jun 2023

10 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 10.925815873948249.ToString("F0")% None 89.07418412605175.ToString("F0")%

Healthcare · as of Dec 31, 2025

VANGUARD GROUP INC holds $67,123,505,993 across 449 Biotechnology names. ANEB ranks #386 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	24,105,823	$10,928,615,912
2	REGN	Regeneron Pharmaceuticals, Inc.	9,075,153	$7,004,838,343
3	ALNY	Alnylam Pharmaceuticals, Inc.	13,553,932	$5,389,721,058
4	INSM	INSMED Inc	21,076,344	$3,668,126,907
5	INCY	Incyte Corp	19,911,434	$1,966,652,333
6	QNCX	Quince Therapeutics, Inc.	2,084,015	$1,396,290,050
7	RVMD	Revolution Medicines, Inc.	16,719,886	$1,331,738,919
8	IONS	Ionis Pharmaceuticals Inc	16,440,459	$1,300,604,709

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2025-12-31	$440,178	435,821	+42.2%	Shares	Defined	2026-01-29
2025-09-30	$766,349	306,540	+41.9%	Shares	Defined	2025-11-07
2025-06-30	$310,969	215,951	+5.6%	Shares	Sole	2025-08-11
2025-03-31	$265,908	204,545	+32.8%	Shares	Sole	2025-05-09
2024-12-31	$258,780	154,036	0.0%	Shares	Sole	2025-02-11
2024-09-30	$297,289	154,036	+0.1%	Shares	Sole	2024-11-13
2024-06-30	$420,073	153,873	+0.3%	Shares	Sole	2024-08-13
2024-03-31	$440,464	153,472	+586.9%	Shares	Sole	2024-05-10
2023-09-30	$68,260	22,344	+39.4%	Shares	Sole	2023-12-18
2023-06-30	$37,675	16,032	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.